CIK 0001834105
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
IMPACT BIOMEDICAL INC.
Sign in to watch- Ticker
- IBO
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 853926944
- Phone
- +1 585-232-1500
- Business address
- 275 WIREGRASS PKWY,, WEST HENRIETTA, NY, 14586
- 4 Open-market buy Chief Executive Officer bought 500 shares at $2.26 ($1,129)
- 4 Open-market buy Chief Executive Officer bought 500 shares at $2.61 ($1,305)
- 4 Open-market buy Chief Executive Officer bought 1,050 shares at an average $2.61 ($2,739)
- 4 Open-market sale 10% owner sold 5,700 shares at an average $2.99 ($17,024)
- 4 Open-market buy 10% owner bought 1,000 shares at $2.33 ($2,330)
- 4 Open-market buy 10% owner bought 57,800 shares at an average $2.65 ($153,220)
- 3/A Insider 3/A
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 2 of 2 · 38 filings